GoodRx Holdings (GDRX) Other financing activities (2020 - 2023)

GoodRx Holdings' Other financing activities history runs 4 years deep, the most recent figure standing at $3.7 million for Q1 2023.

• In Q1 2023, Other financing activities fell 61.2% year-over-year to $3.7 million; the TTM figure through Dec 2025 stood at $3.7 million (up 126.79% YoY), while the FY2024 annual figure was $2.7 million, changed N/A from the prior year.
• Other financing activities came in at $3.7 million for Q1 2023 at GoodRx Holdings, up from -$17.6 million in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $82.3 million in Q4 2020 to a low of -$17.6 million in Q4 2022.
• A 4-year average of $17.2 million and a median of $9.6 million in 2022 frame the typical range for Other financing activities.
• Across the five-year window, Other financing activities jumped 493.62% in 2021 and plunged 130.29% in 2022, its largest moves.
• GoodRx Holdings' Other financing activities stood at $82.3 million in 2020, then retreated by 29.55% to $58.0 million in 2021, then slumped by 130.29% to -$17.6 million in 2022, then surged by 121.13% to $3.7 million in 2023.
• According to Business Quant data, Other financing activities over the past three periods registered $3.7 million, -$17.6 million, and $3.3 million for Q1 2023, Q4 2022, and Q3 2022 respectively.

Peer Comparison